1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. AUROBINDO PHARMA LTD.
Aurobindo Pharma Ltd. NSE: AUROPHARMA | BSE: 524804
Turnaround Potential
In 3 Starfolio Baskets
Download real time
1220.40 -0.30 (-0.02%)
Near 52W High of ₹1278.60
1.8M
NSE+BSE Volume

NSE 27 Feb, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
US FDA Approval
Aurobindo Pharma's arm gets US FDA nod to market Everolimus tablets, with a market size of $78 mn See details

Aurobindo Pharma Delivery Percentage and Volume Analysis for NSE and BSE as of 28 Feb, 2026

Aurobindo Pharma Delivery Traded Volume, Percentages, Week Average and Analysis for NSE and BSE as of 28 Feb, 2026

Delivery Stock Screeners